NCT06296095View on ClinicalTrials.gov

To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 9, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Cirrhosis, Liver
Interventions
BIOLOGICAL

Cell therapy

Subjects were placed sequentially into three different dose groups, 5.0×107 cells/time (low-dose group), 1.5×108 cells/time (medium-dose group), and 5.0×108 cells/time (high-dose group) for dose escalation

Trial Locations (1)

230000

Anhui province hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV